Author

Anna Knöppel

Uppsala University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Organism:Arabidopsis· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Anna af KlerckeriD· 2 shared Gerrit BrandisiD· 2 shared Adam Sundell· 1 shared Carl DamelliD· 1 shared Ellen PaulssoniD· 1 shared Emily ZweifeliD· 1 shared Eric Cruz DavilaiD· 1 shared Greta Melander· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Anna af KlerckerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

16S rRNA Modifications Are Dispensable for Viability but Collectively Optimize Ribosome Biogenesis and Translation Initiation in Escherichia coli

Natalie Åkesson, Anna af Klercker, Maheshwaran Sivakumar, Mikhail Metelev, Anna Knöppel, Magnus Johansson, Gerrit Brandis

This study shows that 16S rRNA modifications are not essential for E. coli viability but improve ribosome biogenesis and translation initiation efficiency.

bioRxiv · Sep 8, 2026 · PreprintMicrobiology

Evolutionary trajectories determine the feasibility of collateral sensitivity based antibiotic treatment strategies in critical bacterial pathogens

Vatsala Chauhan, Lisa Enkvist, Yuliia Chukhareva, Carl Damell, Eric Cruz Davila, Tasnim M. Islam, Greta Melander, Ellen Paulsson, Adam Sundell, Emily Zweifel, Anna af Klercker, Anna Knöppel, Gerrit Brandis

This study investigates collateral sensitivity in bacterial pathogens, finding that resistance mutations can sometimes increase susceptibility to other antibiotics, but these mutations are often costly and not present in clinical isolates.

Communications Biology · Dec 6, 2025Peer-reviewedMicrobiology